Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Return on Capital Employed (2025 - 2026)

Beta Bionics' Return on Capital Employed history spans 2 years, with the latest figure at 26.35% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 240.0% to 26.35% in Q1 2026 year-over-year; TTM through Mar 2026 was 26.35%, a 240.0% decrease, with the full-year FY2025 number at 34.42%, up 721.0% from a year prior.
  • Return on Capital Employed hit 26.35% in Q1 2026 for Beta Bionics, down from 24.02% in the prior quarter.
  • Over the last five years, Return on Capital Employed for BBNX hit a ceiling of 19.88% in Q2 2025 and a floor of 26.35% in Q1 2026.